US Attorney Robert Capers speaks during press conference in New York on December 17, 2015, to announce the unsealing of an indictment charging Martin Shkreli, a former hedge fund manager and Chief Executive Officer of Retrophin. Shkreli, the pharmaceutical CEO who caused a storm in September by jacking up the price of a life-saving drug, was arrested Thursday on fraud charges, prosecutors said. His arrest was not linked to the 5,000-percent increase in the price of Daraprim, a drug used to treat malaria and infections suffered by HIV-positive individuals. The FBI said he was targeted instead in an $11 million embezzlement probe at another company he once led, Retrophin. AFP PHOTO/JEWEL SAMAD / AFP / JEWEL SAMAD (Photo credit should read JEWEL SAMAD/AFP/Getty Images)
